Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Fatigue
ADR ID BADD_A01626
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.002      Fatigue
Description A disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activities. [CTCAE] The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. [MeSH]
MedDRA Code 10016256
MeSH ID D005221
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Enervation | Exhaustion | Exhaustion due to excessive exertion | Exhaustion due to exposure | Fatigability | Fatigability generalized | Fatigability lumbar | Fatigability of knees | Fatigue | Fatigue extreme | Fatiguability | Lassitude | Loss physical strength | Prostration | TATT | Tired all the time | Tired and heavy | Tired out | Tiredness | Washed-out | Weariness | Worn out | Fatigue aggravated | Depressive weariness | Fatigueability generalised | Chronic fatigue | Fatiguability generalised
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01624Orlistat--
BADD_D01627Oseltamivir--
BADD_D01628Oseltamivir phosphate--
BADD_D01629Osimertinib--
BADD_D01633Oxaliplatin--
BADD_D01637Oxcarbazepine--
BADD_D01641Oxprenolol--
BADD_D01643Oxybutynin--
BADD_D01645Oxycodone--
BADD_D01648Oxymorphone--
BADD_D01649Oxymorphone hydrochloride--
BADD_D01653Paclitaxel--
BADD_D01654Palbociclib0.590825%
BADD_D01656Paliperidone--
BADD_D01657Paliperidone palmitate--
BADD_D01659Palonosetron--
BADD_D01660Palonosetron hydrochloride--
BADD_D01661Pamidronate disodium--
BADD_D01662Pamidronic acid--
BADD_D01666Panitumumab--
BADD_D01667Panobinostat lactate--
BADD_D01668Pantoprazole--
BADD_D01669Pantoprazole sodium--
BADD_D01676Paricalcitol--
BADD_D01679Paroxetine--
BADD_D01684Pasireotide0.003539%
BADD_D01685Pasireotide diaspartate--
BADD_D01687Pazopanib0.068881%
BADD_D01688Pazopanib hydrochloride--
BADD_D01690Pegaptanib--
The 26th Page    First    Pre   26 27 28 29 30    Next   Last    Total 40 Pages
ADReCS-Target
ADR Term Drug Name Target